US2010080793A1PendingUtilityA1
DcR3 polypeptide, A TNFR homolog
Est. expirySep 18, 2017(expired)· nominal 20-yr term from priority
Inventors:Avi AshkenaziDavid BotsteinKelly DodgeAudrey GoddardAustin GurneyKyung Jim KimDavid A. LawrenceRobert PittiMargaret RoyDaniel TumasWilliam I. Wood
A61K 38/00C07K 14/70578A01K 2217/05C07K 14/70575C07K 16/2875C12N 2799/026C07K 2317/73A61P 43/00A61P 35/02A61P 35/00C07K 16/2878C07K 2319/00A01K 67/0275
74
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A TNFR homolog, identified as DcR 3 , is provided. Nucleic acid molecules encoding DcR 3 , chimeric molecules and antibodies to DcR 3 are also provided.
Claims
exact text as granted — not AI-modified1 - 54 . (canceled)
55 . An article of manufacture, comprising a container and a composition contained within said container, wherein the composition includes DcR3 polypeptide or DcR3 antibodies.
56 . The article of manufacture of claim 55 further comprising instructions for using the DcR3 polypeptide or DcR3 antibodies in vivo or ex vivo.
57 - 64 . (canceled)
65 . A method of inhibiting a T-cell mediated immune response in a mammal, comprising exposing mammalian cells to DcR3 polypeptide or a chimeric molecule comprising DcR3 polypeptide.
66 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.